Drug intelligence / Profile preview

Phenotypeca HPV vaccine

Development stage: Preclinical
Lead developer: Phenotypeca
Modality: Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Phenotypeca's HPV vaccine is a multi-valent recombinant protein vaccine currently in early-stage development for the prevention of Human Papillomavirus (HPV) infection. The vaccine is produced using Phenotypeca's proprietary *Saccharomyces cerevisiae* yeast strain engineering platform, which employs Quantitative Trait Loci (QTL) mapping to optimize the expression and yield of recombinant viral antigens. This technology is designed to facilitate the low-cost, high-volume manufacturing of complex biologics, making the vaccine potentially more accessible for global health initiatives. The multi-valent formulation is intended to provide broad protection against multiple high-risk HPV genotypes associated with cervical cancer and other malignancies.

Other names: multi-valent HPV vaccine

Beyond the preview

Go deeper on Phenotypeca HPV vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenotypeca HPV vaccine.

Explore the full profile